Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sylvia Andert"'
Publikováno v:
Clinical Biochemistry. 28:291-295
Objectives: The aim of our study was to investigate the usefulness of tissue polypeptide specific antigen, an established tumor marker detecting proliferation of cells, for monitoring heart transplant recipients in order to detect infection and rejec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960aa331fccc0f88663e2516e4726fb2
https://doi.org/10.1016/0009-9120(94)00096-e
https://doi.org/10.1016/0009-9120(94)00096-e
Autor:
Marlene Kindhauser, Andrea Griesmacher, Cyril D. Toma, Rudolf Prager, Christoph Schnack, Sylvia Andert, Mathias M. Mueller, Paul Knoebl, Guntram Schemthaner, Wolfgang Schreiner, Peter Pietschmann
Publikováno v:
The American Journal of Medicine. 98:469-475
To investigate whether serum levels of lipid peroxides measured as thiobarbituric-acid-reactive substances (TBARS) differ in type I and type II diabetic patients, whether serum levels correlate with late sequelae of diabetes, and whether serum levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff5c4e5d5401c0246cb647f8585e363
https://doi.org/10.1016/s0002-9343(99)80347-7
https://doi.org/10.1016/s0002-9343(99)80347-7
Publikováno v:
Scopus-Elsevier
SUMMARYHuman umbilical vein endothelial cells (HUVEC) were investigated for their ability to produce neopterin, a biochemical marker for an activated immune system. Interferon-gamma (IFN-γ), IL-1α, IL-2, IL-6, tumour necrosis factor-alpha, granuloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00102d95306bb530b7e855815d5782dd
https://doi.org/10.1111/j.1365-2249.1992.tb06486.x
https://doi.org/10.1111/j.1365-2249.1992.tb06486.x
Autor:
Georg Wolfbauer, Peter Michael Bayer, Wolfgang Hübl, Sylvia Fitzal, Gunther Stanek, Sylvia Andert, Johannes Streicher
Publikováno v:
Critical care medicine. 27(2)
Objective: To determine the expression of tumor necrosis factor (TNF) receptor in patients with systemic inflammatory response syndrome (SIRS). Design: Prospective study. Setting: Intensive care unit and central laboratory. Patients: Blood specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b66045ab85da36b4c97f9b54f3b02e5
https://pubmed.ncbi.nlm.nih.gov/10075034
https://pubmed.ncbi.nlm.nih.gov/10075034
Autor:
Johannes Streicher, Sylvia Andert, Peter Michael Bayer, Alexander Lapin, Wolfgang Hübl, Christin Hübner, Georg Wolfbauer, Gabriele Thum
Publikováno v:
Cytometry. 30(2)
A flow cytometric method performing a five-part leukocyte differential based on three-color staining with anti-CD45-fluorescein isothiocyanate (FITC), anti-CD-14-phycoerythrin (PE)/Cy5, and a cocktail of PE-labeled anti-CD2, anti-CD16, and anti-HLA-D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3484ceb471e6291543c9a478d566f1
https://pubmed.ncbi.nlm.nih.gov/9149914
https://pubmed.ncbi.nlm.nih.gov/9149914
Publikováno v:
Cytometry. 26(1)
Flow cytometry using fluorescence-labelled monoclonal antibodies has been proposed as a possible new reference method to evaluate the monocyte counting performance of automated hematology analyzers. Since in previous studies only one such technique w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ca34ac7a760021eed7e0f963171656a
https://pubmed.ncbi.nlm.nih.gov/8809484
https://pubmed.ncbi.nlm.nih.gov/8809484
Flow cytometric enumeration of monocytes stained with fluorescence-labelled monoclonal antibodies has been proposed as a possible reference method for monocyte counting. We compared precision and accuracy of monocyte counting of the Coulter STKS, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979db561d2f4f0c07d50fad424806378
http://edoc.hu-berlin.de/18452/12748
http://edoc.hu-berlin.de/18452/12748
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 224(2)
The use of cyclosporin A (CyA) as an immunosuppressive drug is limited because of its serious side effects. In order to minimise these toxic side effects while utilising immunosuppressive properties of CyA, the dosage of CyA is generally administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f753547f47d29b5d22f5e02d4eb12b25
https://pubmed.ncbi.nlm.nih.gov/8004786
https://pubmed.ncbi.nlm.nih.gov/8004786